Oorja Bio Begins ORJ-001 Pulmonary Fibrosis Trial: A Critical Test for a New Approach
ORJ-001 pulmonary fibrosis trial begins: Oorja Bio screens its first patient in Phase 2. The drug is experimental and no efficacy results exist yet.
Tag: idiopathic pulmonary fibrosis
Read More